Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 36

1.

Prevention of hemodialysis catheter infections: Ointments, dressings, locks, and catheter hub devices.

Golestaneh L, Mokrzycki MH.

Hemodial Int. 2018 Oct;22(S2):S75-S82. doi: 10.1111/hdi.12703. Epub 2018 Nov 8. Review.

PMID:
30411464
2.

Recommended Clinical Trial End Points for Dialysis Catheters.

Allon M, Brouwer-Maier DJ, Abreo K, Baskin KM, Bregel K, Chand DH, Easom AM, Mermel L, Mokrzycki MH, Patel PR, Roy-Chaudhury P, Shenoy S, Valentini RP, Wasse H.

Clin J Am Soc Nephrol. 2018 Mar 7;13(3):495-500. doi: 10.2215/CJN.12011116. Epub 2017 Jul 20.

3.

Optimal Approach for the Diagnosis of Hemodialysis Catheter-Related Bacteremia.

Johns TS, Mokrzycki MH.

Clin J Am Soc Nephrol. 2016 May 6;11(5):756-8. doi: 10.2215/CJN.02910316. Epub 2016 Apr 1. No abstract available.

4.

Complete Remission in the Nephrotic Syndrome Study Network.

Gipson DS, Troost JP, Lafayette RA, Hladunewich MA, Trachtman H, Gadegbeku CA, Sedor JR, Holzman LB, Moxey-Mims MM, Perumal K, Kaskel FJ, Nelson PJ, Tuttle KR, Bagnasco SM, Hogan MC, Dell KM, Appel GB, Lieske JC, Ilori TO, Sethna CB, Fervenza FC, Hogan SL, Nachman PH, Rosenberg AZ, Greenbaum LA, Meyers KE, Hewitt SM, Choi MJ, Kopp JB, Zhdanova O, Hodgin JB, Johnstone DB, Adler SG, Avila-Casado C, Neu AM, Hingorani SR, Lemley KV, Nast CC, Brady TM, Barisoni-Thomas L, Fornoni A, Jennette JC, Cattran DC, Palmer MB, Gibson KL, Reich HN, Mokrzycki MH, Sambandam KK, Zilleruelo GE, Licht C, Sampson MG, Song P, Mariani LH, Kretzler M.

Clin J Am Soc Nephrol. 2016 Jan 7;11(1):81-9. doi: 10.2215/CJN.02560315. Epub 2015 Dec 10.

5.

Optimizing Central Venous Catheter Primary Prevention Trials in Hemodialysis Patients.

Mokrzycki MH, Lok CE.

Am J Kidney Dis. 2015 Dec;66(6):939-41. doi: 10.1053/j.ajkd.2015.09.003. No abstract available.

PMID:
26593313
6.

Understanding surgical preference and practice in hemodialysis vascular access creation.

Nica A, Lok CE, Harris J, Lee TC, Mokrzycki MH, Maya ID, Vazquez MA, Xi W, Moist LM; North American Vascular Access Consortium (NAVAC).

Semin Dial. 2013 Jul-Aug;26(4):520-6. doi: 10.1111/sdi.12046. Epub 2013 Mar 21.

PMID:
23517536
7.

Vascular access in therapeutic apheresis: update 2013.

Golestaneh L, Mokrzycki MH.

J Clin Apher. 2013 Feb;28(1):64-72. doi: 10.1002/jca.21267. Review.

PMID:
23420596
8.

The initial vascular access type contributes to inflammation in incident hemodialysis patients.

Sachdeva M, Hung A, Kovalchuk O, Bitzer M, Mokrzycki MH.

Int J Nephrol. 2012;2012:917465. doi: 10.1155/2012/917465. Epub 2011 Oct 25.

9.

APOL1 genetic variants in focal segmental glomerulosclerosis and HIV-associated nephropathy.

Kopp JB, Nelson GW, Sampath K, Johnson RC, Genovese G, An P, Friedman D, Briggs W, Dart R, Korbet S, Mokrzycki MH, Kimmel PL, Limou S, Ahuja TS, Berns JS, Fryc J, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Vlahov D, Pollak M, Winkler CA.

J Am Soc Nephrol. 2011 Nov;22(11):2129-37. doi: 10.1681/ASN.2011040388. Epub 2011 Oct 13.

10.

Therapeutic apheresis: a review of complications and recommendations for prevention and management.

Mokrzycki MH, Balogun RA.

J Clin Apher. 2011;26(5):243-8. doi: 10.1002/jca.20303. Epub 2011 Sep 5. Review.

PMID:
21898573
11.

Prevention and management of catheter-related infection in hemodialysis patients.

Lok CE, Mokrzycki MH.

Kidney Int. 2011 Mar;79(6):587-598. doi: 10.1038/ki.2010.471. Epub 2010 Dec 22. Review.

12.

Traditional and non-traditional strategies to optimize catheter function: go with more flow.

Mokrzycki MH, Lok CE.

Kidney Int. 2010 Dec;78(12):1218-31. doi: 10.1038/ki.2010.332. Epub 2010 Sep 29. Review.

13.

Introduction and overview of therapeutic apheresis.

Okafor C, Ward DM, Mokrzycki MH, Weinstein R, Clark P, Balogun RA.

J Clin Apher. 2010;25(5):240-9. doi: 10.1002/jca.20247. Review. No abstract available.

PMID:
20806281
14.

Who should be referred for a fistula? A survey of nephrologists.

Xi W, MacNab J, Lok CE, Lee TC, Maya ID, Mokrzycki MH, Moist LM.

Nephrol Dial Transplant. 2010 Aug;25(8):2644-51. doi: 10.1093/ndt/gfq064. Epub 2010 Feb 22.

15.

Removal of vancomycin in sustained low-efficiency dialysis (SLED): a need for better surveillance and dosing.

Golestaneh L, Gofran A, Mokrzycki MH, Chen JL.

Clin Nephrol. 2009 Oct;72(4):286-91.

PMID:
19825334
16.

Vascular access type and changes in inflammatory markers in incident dialysis patients: a pilot study.

Sachdeva M, Kovalchuk O, Bitzer M, Mokrzycki MH.

J Vasc Access. 2009 Jul-Sep;10(3):174-9.

PMID:
19670170
17.

MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Kopp JB, Smith MW, Nelson GW, Johnson RC, Freedman BI, Bowden DW, Oleksyk T, McKenzie LM, Kajiyama H, Ahuja TS, Berns JS, Briggs W, Cho ME, Dart RA, Kimmel PL, Korbet SM, Michel DM, Mokrzycki MH, Schelling JR, Simon E, Trachtman H, Vlahov D, Winkler CA.

Nat Genet. 2008 Oct;40(10):1175-84. doi: 10.1038/ng.226. Epub 2008 Sep 14.

18.

Use of prophylactic topical or intraluminal antibiotics for hemodialysis catheters.

Mokrzycki MH.

Nat Clin Pract Nephrol. 2008 Sep;4(9):478-9. doi: 10.1038/ncpneph0894. Epub 2008 Jul 22.

PMID:
18648344
19.

NPHS2 variation in sporadic focal segmental glomerulosclerosis.

McKenzie LM, Hendrickson SL, Briggs WA, Dart RA, Korbet SM, Mokrzycki MH, Kimmel PL, Ahuja TS, Berns JS, Simon EE, Smith MC, Trachtman H, Michel DM, Schelling JR, Cho M, Zhou YC, Binns-Roemer E, Kirk GD, Kopp JB, Winkler CA.

J Am Soc Nephrol. 2007 Nov;18(11):2987-95. Epub 2007 Oct 17.

20.
21.

Tunnelled haemodialysis catheter bacteraemia: risk factors for bacteraemia recurrence, infectious complications and mortality.

Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO.

Nephrol Dial Transplant. 2006 Apr;21(4):1024-31. Epub 2006 Jan 31.

PMID:
16449293
22.

Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.

Golestaneh L, Laut J, Rosenberg S, Zhang M, Mokrzycki MH.

Nephrol Dial Transplant. 2006 May;21(5):1328-33. Epub 2006 Jan 18.

PMID:
16421157
23.

Large atrial thrombus formation associated with tunneled cuffed hemodialysis catheters.

Negulescu O, Coco M, Croll J, Mokrzycki MH.

Clin Nephrol. 2003 Jan;59(1):40-6. Review.

PMID:
12572930
24.
25.

Novel WT1 mutation (C388Y) in a female child with Denys-Drash syndrome.

Swiatecka-Urban A, Mokrzycki MH, Kaskel F, Da Silva F, Denamur E.

Pediatr Nephrol. 2001 Aug;16(8):627-30.

PMID:
11519891
26.

A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters.

Mokrzycki MH, Jean-Jerome K, Rush H, Zdunek MP, Rosenberg SO.

Kidney Int. 2001 May;59(5):1935-42.

27.

Levofloxacin-induced allergic interstitial nephritis.

Solomon NM, Mokrzycki MH.

Clin Nephrol. 2000 Oct;54(4):356. No abstract available.

PMID:
11076114
28.

Tunneled-cuffed catheter associated infections in hemodialysis patients who are seropositive for the human immunodeficiency virus.

Mokrzycki MH, Schröppel B, von Gersdorff G, Rush H, Zdunek MP, Feingold R.

J Am Soc Nephrol. 2000 Nov;11(11):2122-7.

29.
30.

Lactic acidosis associated with stavudine administration: a report of five cases.

Mokrzycki MH, Harris C, May H, Laut J, Palmisano J.

Clin Infect Dis. 2000 Jan;30(1):198-200.

PMID:
10619755
31.
32.

Protein losses in continuous renal replacement therapies.

Mokrzycki MH, Kaplan AA.

J Am Soc Nephrol. 1996 Oct;7(10):2259-63.

34.
35.

Therapeutic plasma exchange: complications and management.

Mokrzycki MH, Kaplan AA.

Am J Kidney Dis. 1994 Jun;23(6):817-27.

PMID:
8203364
36.

Renal malacoplakia with papillary necrosis and renal failure.

Mokrzycki MH, Yamase H, Kohn OF.

Am J Kidney Dis. 1992 Jun;19(6):587-91.

PMID:
1595708

Supplemental Content

Loading ...
Support Center